Source: BioPortfolio

Ensemble Therapeutics: Ensemble Therapeutics Corporation Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryEnsemble Therapeutics Corporation Ensemble is a biotechnology company that provides therapeutics and diagnostics for oncology therapy. The company is developing Ensemblins which is a synthetic macrocycle drug to treat diseases by addressing drug tar...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Ripple's photo - CEO of Ensemble Therapeutics

CEO

John Ripple

CEO Approval Rating

70/100

Read more